The influence of recombinant antagonist interleukin-1 receptors on the course of tetrachloromethane hepatitis in rats
DOI:
https://doi.org/10.24959/cphj.14.1231Keywords:
ARIL-1, tetrachlorinemethane hepatitis, hepatoprotective actionAbstract
As we know, the growth of the abundance and morbidity indicators, poor treatment outcomes, inadequate diagnosis define the problem of chronic liver disease as one of the most complex in modern medicine. In the pathogenesis of the severe inflammatory response in hepatitis of different genesis with development of liver failure and cholestasis the main role belongs to cytokines that are involved in attracting inflammatory cells in the lesion, which leads to the death of hepatocytes. Interleukin-1 (IL-1), which is one of the most important pro-inflammatory cytokines, occupies an important place in the process of liver damage in hepatitis. Taking into account a significant role of IL-1 in development of inflammation and cytolysis of hepatocytes the aim of our research was to determine the hepatoprotective action of the original recombinant receptor antagonist IL-1 on the model of chronic tetrachloromethane hepatitis in rats. The article gives the results of the experimental study of the influence of the original recombinant antagonist interleukin-1 receptors (ARIL-1) on development of chronic tetrachlorоmethane hepatitis in rats. The experimental liver damage was caused by a subcutaneous injection of carbon tetrachloride in the dose of 0.2 ml/100 g twice a week for 60 days. Herbal hepatoprotector Silibor was selected as a reference medicine. It has been found that ARIL-1 exceeds Silibor by its influence on the INC, survival of animals, the ALT activity, urea level, total protein in the serum, the content of DC and TBA-P in the rat liver homogenate. It allows to conclude that ARIL-1 is not inferior to the reference medicine by its hepatoprotective effect, and even exceeds it in the anti-inflammatory and antioxidant activity.
References
Арутюнян А.В., Дубинина Е.Е., Зыбина Н.Н. Методы оценки свободнорадикального окисления и антиоксидантной системы организма: Метод. рекоменд. – С.Пб.: ИКФ «Фолиант», 2000. – 104 с.
Доклінічні дослідження лікарських засобів: Метод. рекоменд. / За ред. чл.-кор. НАМН України О.В.Стефанова. – К.: Авіценна, 2001. – 528 c.
Ивашкин В.Т., Маммаев С.Н., Лукина Е.А. // Иммунол. – 2001. – №1. – С. 46-49.
Игнатов В.А. // Сучасна гастроентерол. – 2001. – №3. – С. 59-61.
Камышников В.С. Справочник по клиническо-биохимической лабораторной диагностике: в 2-х т. – Мн: Беларусь. – Т. 1. – 2002. – 495 с.; Т. 2. – 2003. – 463 с.
Кетлинский С.С., Симбирцев А.С. Цитокины. – М.: Фолиант, 2008. – 552 с.
Конусова В.Г., Романова Е.С., Чурилова И.В. и др. // Цитокины и воспаление. – 2003. – Т. 2, №1. – С. 20-28.
Любимов А.С., Калинина Н.М., Сысоев К.А. // Мед. иммунол. – 2001. – Т. 3, №2. – С. 226.
Меньшиков В.В., Делекторская Л.Н., Золотницкая Р.П. и др. Лабораторные методы исследования в клинике: Справочник / Под ред. В.В.Меньшикова. – М.: Медицина, 1997. – 368 с.
Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. – 3-е изд. – М.: МедиаСфера, 2006. – 312 с.
Хабиор А. // Достижения в области мед. наук. – 2009. – №2. – С. 1977-1983.
Boermeester M.A., Straatsburg I.H., Houdijk A.P. et al. // Hepatol. – 1995. – Vol. 22. – P. 1499-1506.
Dinarello C.A. // Arthritis Rheum. – 2005. – Vol. 52, №11. – P. 1960-1967.
Dinarello C.A. // Ann. Rev. Immunol. – 2009. – Vol. 27. – P. 519-550.
Gabay C., Lamacchia C., Palmer G. // Nat. Rev. Rheumatol. – 2010. – №6. – P. 232-241.
Gabay C., Gigley J., Sipe J. et al. // Eur. J. Immunol. – 2001. – Vol. 31. – Р. 490-499.
Galun E., Axelrod J.H. // Biochim. Biophys. Acta. – 2002. – Vol. 1592. – P. 345-358.
Hallegua D.S., Weisman M.H. // Ann. Rheum. Dis. – 2002. – Vol. 61, №11. – Р. 960-967.
Wang Z., Wang M., Carr B.I. // Hepatol. – 1998. – Vol. 28. – P. 430-435.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
